Condensed Consolidated Interim Statements of Changes in Stockholders’ Equity (Unaudited)
| Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’ |
|---|
| Number** | Amount** | capital** | loss | deficit | equity |
|---|
| Balance as of January 1, 2024 | 452,724 | 1 | 65,386 | (771) | (59,881) | 4,735 |
|---|
| Stock-based compensation related to options granted to employees and consultants | 80,000 | -* | 217 | - | - | 217 |
|---|
| Issuance of shares post Business Combination | 4,360 | -* | 3 | - | - | 3 |
|---|
| Effect of reverse stock split | 74,683 | -* | - | - | - | - |
|---|
| Issuance of shares, net of issuance cost of $442 (***) | 79,000 | -* | 2,819 | - | - | 2,819 |
|---|
| Exercise of shares in abeyance | 192,364 | -* | - | - | - | - |
|---|
| Total comprehensive loss | - | - | - | (99) | (1,980) | (2,079) |
|---|
| Balance as of June 30, 2024 | 883,131 | 1 | 68,425 | (870) | (61,861) | 5,695 |
|---|
| (*) | Represents an amount less than $1. |
|---|
| (**) | Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d). |
|---|
| (***) | See note 8 (f). |
|---|
| Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’ |
|---|
| Number** | Amount** | Capital** | loss | deficit | equity |
|---|
| Balance as of January 1, 2023 | 183,015 | 1 | 58,673 | (637) | (53,501) | 4,536 |
|---|
| Stock-based compensation related to options granted to employees and consultants | (1,000) | -* | 222 | - | - | 222 |
|---|
| Issuance of shares, net of issuance cost of $341(**) | 20,250 | -* | 2,658 | - | - | 2,658 |
|---|
| Exercise of warrants and prefunded warrants | 102,583 | -* | 1 | - | - | 1 |
|---|
| Total comprehensive loss | - | - | - | (39) | (3,945) | (3,984) |
|---|
| Balance as of June 30, 2023 | 304,848 | 1 | 61,554 | (676) | (57,446) | 3,433 |
|---|
| (*) | Represents an amount less than $1 |
|---|
| (**) | Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d). |
|---|
| Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’ |
|---|
| Number** | Amount** | Capital** | loss | deficit | equity |
|---|
| Balance as of April 1, 2024 | 641,459 | 1 | 65,527 | (878) | (60,897) | 3,753 |
|---|
| Stock-based compensation related to options granted to employees and consultants | - | | 79 | - | - | 79 |
|---|
| Effect of reverse stock split | 74,683 | -* | - | - | - | - |
|---|
| Issuance of shares, net of issuance cost of $442 (***) | 79,000 | -* | 2,819 | - | - | 2,819 |
|---|
| Exercise of warrants and prefunded warrants | 87,989 | -* | - | - | - | - |
|---|
| Total comprehensive loss | - | - | - | 8 | (964) | (956) |
|---|
| Balance as of June 30, 2024 | 883,131 | 1 | 68,425 | (870) | (61,861) | 5,695 |
|---|
| (*) | Represents an amount less than $1 |
|---|
| (**) | Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d). |
|---|
| (***) | See note 8 (f). |
|---|
| Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’ |
|---|
| Number** | Amount** | Capital** | loss | deficit | equity |
|---|
| Balance as of April 1, 2023 | 305,848 | 1 | 61,468 | (652) | (56,155) | 4,662 |
|---|
| Stock-based compensation related to options granted to employees and consultants | (1,000) | -* | 86 | - | - | 86 |
|---|
| Total comprehensive loss | - | - | - | (24) | (1,291) | (1,315) |
|---|
| Balance as of June 30, 2023 | 304,848 | 1 | 61,554 | (676) | (57,446) | 3,433 |
|---|
| (*) | Represents an amount less than $1 |
|---|
| (**) | Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d). |
|---|
| Common stock · Additional paid-in · Accumulated other comprehensive · Accumulated · Total stockholders’ |
|---|
| Number** | Amount** | capital** | loss | deficit | equity |
|---|
| Balance as of December 31, 2022 | 183,015 | 1 | 58,673 | (637) | (53,501) | 4,536 |
|---|
| Stock-based compensation related to options and restricted shares granted to employees and consultants | (1,000) | -(*) | 453 | - | - | 453 |
|---|
| Issuance of shares, net of issuance cost of $959 | 54,000 | -(*) | 6,258 | - | - | 6,258 |
|---|
| Exercise of shares in abeyance | 216,709 | -(*) | 2 | - | - | 2 |
|---|
| Total comprehensive loss | - | - | - | (134) | (6,380) | (6,514) |
|---|
| Balance as of December 31, 2023 | 452,724 | 1 | 65,386 | (771) | (59,881) | 4,735 |
|---|
| (*) | Represents an amount less than $1. |
|---|
| (**) | Adjusted to give retroactive effect of 1:8 reverse stock split, see note 8 (d). |
|---|